HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Focal adhesion kinase as an immunotherapeutic target.

AbstractBACKGROUND:
Focal adhesion kinase (FAK) is a ubiquitously expressed non-receptor tyrosine kinase involved in cancer progression and metastasis that is found overexpressed in a large number of tumors such as breast, colon, prostate, melanoma, head and neck, lung and ovary. Thus, FAK could be an attractive tumor associated antigen (TAA) for developing immunotherapy against a broad type of malignancies. In this study, we determined whether predicted T cell epitopes from FAK would be able to induce anti-tumor immune cellular responses.
METHODS:
To validate FAK as a TAA recognized by CD4 helper T lymphocytes (HTL), we have combined the use of predictive peptide/MHC class II binding algorithms with in vitro vaccination of CD4 T lymphocytes from healthy individuals and melanoma patients.
RESULTS:
Two synthetic peptides, FAK(143-157) and FAK(1,000-1,014), induced HTL responses that directly recognized FAK-expressing tumor cells and autologous dendritic cells pulsed with FAK-expressing tumor cell lysates in an HLA class II-restricted manner. Moreover, since the FAK peptides were recognized by melanoma patient's CD4 T cells, this is indicative that T cell precursors reactive with FAK already exist in peripheral blood of these patients.
CONCLUSIONS:
Our results provide evidence that FAK functions as a TAA and describe peptide epitopes that may be used for designing T cell-based immunotherapy for FAK-expressing cancers, which could be used in combination with newly developed FAK inhibitors.
AuthorsHiroya Kobayashi, Makoto Azumi, Yuka Kimura, Keisuke Sato, Naoko Aoki, Shoji Kimura, Masaru Honma, Hajime Iizuka, Masatoshi Tateno, Esteban Celis
JournalCancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 58 Issue 6 Pg. 931-40 (Jun 2009) ISSN: 1432-0851 [Electronic] Germany
PMID18941742 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antigens, Neoplasm
  • Epitopes, T-Lymphocyte
  • Peptide Fragments
  • Focal Adhesion Protein-Tyrosine Kinases
Topics
  • Antigens, Neoplasm (immunology)
  • Blotting, Western
  • CD4-Positive T-Lymphocytes (immunology)
  • Epitopes, T-Lymphocyte (immunology)
  • Focal Adhesion Protein-Tyrosine Kinases (immunology)
  • Genes, MHC Class II (physiology)
  • Humans
  • Immunoenzyme Techniques
  • Immunotherapy
  • Melanoma (therapy)
  • Peptide Fragments (immunology)
  • T-Lymphocytes, Helper-Inducer (immunology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: